The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5233-5242

  Linke, Björn ^a   Abeler Dörner, Lucie ^a,b   Jahndel, Veronika ^a,c   Kurz, Alexandra ^a   Mahr, Andrea ^a,d   Pfrang, Sandra ^a   Linke, Linda ^a   Krammer, Peter H ^a   Weyd, Heiko ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BIONTECH AG   (Germany)

^d IMMATICS BIOTECHNOLOGIES GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN A13; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; L SELECTIN; LIPOCORTIN 1; LIPOCORTIN 5; MESSENGER RNA; OVALBUMIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANNEXIN A1, MOUSE; CYTOKINE; FORMYLPEPTIDE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANNEXIN CORE DOMAIN; APOPTOSIS; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL STIMULATION; CELL SURFACE; CELL VIABILITY; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; UPREGULATION; ANIMAL; AUTOIMMUNE DISEASE; BONE MARROW CELL; C57BL MOUSE; DENDRITIC CELL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; NEOPLASM; PHAGOCYTE; PROTEIN TERTIARY STRUCTURE; SECRETION (PROCESS);

ANIMALS; ANNEXIN A1; ANNEXIN A5; APOPTOSIS; AUTOIMMUNE DISEASES; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; PHAGOCYTES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, FORMYL PEPTIDE; TOLL-LIKE RECEPTORS;

EID: 84929650437     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401299     Document Type: Article

References (67)

1. Mueller, D. L. 2010. Mechanisms maintaining peripheral tolerance. Nat. Immunol. 11: 21-27.
2. Huang, F. P., N. Platt, M. Wykes, J. R. Major, T. J. Powell, C. D. Jenkins, and G. G. MacPherson. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191: 435-444.
3. Gregory, C. D., and A. Devitt. 2004. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113: 1-14.
4. Bedoui, S., P. G. Whitney, J. Waithman, L. Eidsmo, L. Wakim, I. Caminschi, R. S. Allan, M. Wojtasiak, K. Shortman, F. R. Carbone, et al. 2009. Crosspresentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10: 488-495.
5. Bursch, L. S., L. Wang, B. Igyarto, A. Kissenpfennig, B. Malissen, D. H. Kaplan, and K. A. Hogquist. 2007. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204: 3147-3156.
6. del Rio, M. L., J. I. Rodriguez-Barbosa, E. Kremmer, and R. Förster. 2007. CD1032 and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178: 6861-6866.
7. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Díaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258.
8. Scott, R. S., E. J. McMahon, S. M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H. S. Earp, and G. K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211.
9. Kawane, K., M. Ohtani, K. Miwa, T. Kizawa, Y. Kanbara, Y. Yoshioka, H. Yoshikawa, and S. Nagata. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998-1002.
10. Wallet, M. A., P. Sen, R. R. Flores, Y. Wang, Z. Yi, Y. Huang, C. E. Mathews, H. S. Earp, G. Matsushima, B. Wang, and R. Tisch. 2008. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 205: 219-232.
11. Weyd, H., L. Abeler-Dörner, B. Linke, A. Mahr, V. Jahndel, S. Pfrang, M. Schnölzer, C. S. Falk, and P. H. Krammer. 2013. Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. PLoS ONE 8: e62449. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone. 0062449.
12. Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82: 331-371.
13. Moss, S. E., and R. O. Morgan. 2004. The annexins. Genome Biol. 5: 219.
14. Raynal, P., and H. B. Pollard. 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipidbinding proteins. Biochim. Biophys. Acta 1197: 63-93.
15. Walther, A., K. Riehemann, and V. Gerke. 2000. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5: 831-840.
16. Ernst, S., C. Lange, A. Wilbers, V. Goebeler, V. Gerke, and U. Rescher. 2004. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J. Immunol. 172: 7669-7676.
17. Strausbaugh, H. J., and S. D. Rosen. 2001. A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells. J. Immunol. 166: 6294-6300.
18. Perretti, M., and J. Dalli. 2009. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br. J. Pharmacol. 158: 936-946.
19. Hayhoe, R. P., A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti. 2006. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107: 2123-2130.
20. Pupjalis, D., J. Goetsch, D. J. Kottas, V. Gerke, and U. Rescher. 2011. Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol. Med. 3: 102-114.
21. Wallner, B. P., R. J. Mattaliano, C. Hession, R. L. Cate, R. Tizard, L. K. Sinclair, C. Foeller, E. P. Chow, J. L. Browing, K. L. Ramachandran, et al. 1986. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320: 77-81.
22. Davidson, F. F., M. D. Lister, and E. A. Dennis. 1990. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line. J. Biol. Chem. 265: 5602-5609.
23. Kim, S. W., H. J. Rhee, J. Ko, Y. J. Kim, H. G. Kim, J. M. Yang, E. C. Choi, and D. S. Na. 2001. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J. Biol. Chem. 276: 15712-15719.
24. Kamal, A. M., R. P. Hayhoe, A. Paramasivam, D. Cooper, R. J. Flower, E. Solito, and M. Perretti. 2006. Antiflammin-2 activates the human formyl-peptide receptor like 1. ScientificWorldJournal 6: 1375-1384.
25. Farber, S. A., R. A. De Rose, E. S. Olson, and M. E. Halpern. 2003. The zebrafish annexin gene family. Genome Res. 13(6A): 1082-1096.
26. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
27. Naik, S. H., A. I. Proietto, N. S. Wilson, A. Dakic, P. Schnorrer, M. Fuchsberger, M. H. Lahoud, M. O'Keeffe, Q. X. Shao, W. F. Chen, et al. 2005. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
28. Brachvogel, B., J. Dikschas, H. Moch, H. Welzel, K. von der Mark, C. Hofmann, and E. Pöschl. 2003. Annexin A5 is not essential for skeletal development. Mol. Cell. Biol. 23: 2907-2913.
29. Hawkins, T. E., J. Roes, D. Rees, J. Monkhouse, and S. E. Moss. 1999. Immunological development and cardiovascular function are normal in annexin VI null mutant mice. Mol. Cell. Biol. 19: 8028-8032.
30. Herr, C., N. Smyth, S. Ullrich, F. Yun, P. Sasse, J. Hescheler, B. Fleischmann, K. Lasek, K. Brixius, R. H. Schwinger, et al. 2001. Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes. Mol. Cell. Biol. 21: 4119-4128.
31. Ling, Q., A. T. Jacovina, A. Deora, M. Febbraio, R. Simantov, R. L. Silverstein, B. Hempstead, W. H. Mark, and K. A. Hajjar. 2004. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 113: 38-48.
32. Hannon, R., J. D. Croxtall, S. J. Getting, F. Roviezzo, S. Yona, M. J. Paul-Clark, F. N. Gavins, M. Perretti, J. F. Morris, J. C. Buckingham, and R. J. Flower. 2003. Aberrant inflammation and resistance to glucocorticoids in annexin 12/2 mouse. FASEB J. 17: 253-255.
33. Iglesias, J. M., R. O. Morgan, N. A. Jenkins, N. G. Copeland, D. J. Gilbert, and M. P. Fernandez. 2002. Comparative genetics and evolution of annexin A13 as the founder gene of vertebrate annexins. Mol. Biol. Evol. 19: 608-618.
34. Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, and K. Inaba. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
35. Ip, W. K., and Y. L. Lau. 2004. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 173: 189-196.
36. Stuart, L. M., M. Lucas, C. Simpson, J. Lamb, J. Savill, and A. Lacy-Hulbert. 2002. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 168: 1627-1635.
37. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097.
38. Skoberne, M., S. Somersan,W. Almodovar, T. Truong, K. Petrova, P. M. Henson, and N. Bhardwaj. 2006. The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood 108: 947-955.
39. Urban, B. C., N. Willcox, and D. J. Roberts. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98: 8750-8755.
40. Krispin, A., Y. Bledi, M. Atallah, U. Trahtemberg, I. Verbovetski, E. Nahari, O. Zelig, M. Linial, and D. Mevorach. 2006. Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood 108: 3580-3589.
41. Adler, A. J., D. W. Marsh, G. S. Yochum, J. L. Guzzo, A. Nigam, W. G. Nelson, and D. M. Pardoll. 1998. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med. 187: 1555-1564.
42. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
43. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
44. Janssen, E. M., N. M. Droin, E. E. Lemmens, M. J. Pinkoski, S. J. Bensinger, B. D. Ehst, T. S. Griffith, D. R. Green, and S. P. Schoenberger. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activationinduced cell death. Nature 434: 88-93.
45. Kawahata, K., Y. Misaki, M. Yamauchi, S. Tsunekawa, K. Setoguchi, J. Miyazaki, and K. Yamamoto. 2002. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168: 4399-4405.
46. Probst, H. C., K. McCoy, T. Okazaki, T. Honjo, and M. van den Broek. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280-286.
47. Monceau, V., Y. Belikova, G. Kratassiouk, D. Charue, E. Camors, C. Communal, P. Trouvé, F. Russo-Marie, and D. Charlemagne. 2004. Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes. Cardiovasc. Res. 64: 496-506.
48. Kaneko, N., R. Matsuda, S. Hosoda, T. Kajita, and Y. Ohta. 1996. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin. Chim. Acta 251: 65-80.
49. Matsuda, R., N. Kaneko, Y. Horikawa, F. Chiwaki, M. Shinozaki, T. Ieiri, T. Suzuki, and N. Ogawa. 2001. Localization of annexin V in rat normal kidney and experimental glomerulonephritis. Res. Exp. Med. (Berl.) 200: 77-92.
50. Sen, P., M. A. Wallet, Z. Yi, Y. Huang, M. Henderson, C. E. Mathews, H. S. Earp, G. Matsushima, A. S. Baldwin, Jr., and R. M. Tisch. 2007. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109: 653-660.
51. Verbovetski, I., H. Bychkov, U. Trahtemberg, I. Shapira, M. Hareuveni, O. Ben-Tal, I. Kutikov, O. Gill, and D. Mevorach. 2002. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, downregulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196: 1553-1561.
52. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
53. Fujii, S., K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199: 1607-1618.
54. Joffre, O., M. A. Nolte, R. Spö rri, and C. Reis e Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227: 234-247.
55. Serhan, C. N., S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21: 325-332.
56. Serhan, C. N., J. Z. Haeggström, and C. C. Leslie. 1996. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10: 1147-1158.
57. Kim, K. M., D. K. Kim, Y. M. Park, C. K. Kim, and D. S. Na. 1994. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 343: 251-255.
58. Solito, E., A. Mulla, J. F. Morris, H. C. Christian, R. J. Flower, and J. C. Buckingham. 2003. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144: 1164-1174.
59. Solito, E., C. de Coupade, S. Canaider, N. J. Goulding, and M. Perretti. 2001. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br. J. Pharmacol. 133: 217-228.
60. Solito, E., A. Kamal, F. Russo-Marie, J. C. Buckingham, S. Marullo, and M. Perretti. 2003. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17: 1544-1546.
61. Gidon-Jeangirard, C., E. Solito, A. Hofmann, F. Russo-Marie, J. M. Freyssinet, and M. C. Martínez. 1999. Annexin V counteracts apoptosis while inducing Ca(2+) influx in human lymphocytic T cells. Biochem. Biophys. Res. Commun. 265: 709-715.
62. Miele, L., E. Cordella-Miele, A. Facchiano, and A. B. Mukherjee. 1988. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 335: 726-730.
63. Perretti, M., N. Chiang, M. La, I. M. Fierro, S. Marullo, S. J. Getting, E. Solito, and C. N. Serhan. 2002. Endogenous lipid- and peptide-derived antiinflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8: 1296-1302.
64. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638.
65. Haynes, N. M., R. G. van der Most, R. A. Lake, and M. J. Smyth. 2008. Immunogenic anti-cancer chemotherapy as an emerging concept. Curr. Opin. Immunol. 20: 545-557.
66. van der Most, R. G., A. J. Currie, B. W. Robinson, and R. A. Lake. 2008. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. Cell Death Differ. 15: 13-20.
67. Garg, A. D., D. Nowis, J. Golab, P. Vandenabeele, D. V. Krysko, and P. Agostinis. 2010. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim. Biophys. Acta 1805: 53-71.